Medtech 2020 Outlook: Data Reigns Supreme For Device Investors
2019 was a robust year for device fundraising and the trend will continue this year according to Nooman Haque, managing director of life sciences and healthcare at Silicon Valley Bank’s UK branch. However, medtech companies without a data proposition may find themselves struggling to compete.
You may also be interested in...
Barcode Diagnostics is developing a nanotechnology for personalized cancer drug screening. The start-up’s aim is to provide physicians with a tool that matches patients with the most effective medicine, during the different stages of disease.
Dutch data-capture company Castor is aiming to make the world’s medical research data reusable. The cloud-based platform enables medical device companies to capture, process and integrate data from multiple sources on a centralized platform.
Ophthalmic start-up CorNeat Vision is entering a multi-center clinical trial for its artificial cornea device CorNeat KPro. The implant uses advanced cell technology to biomimic the cellular structure of the eye and integrate with tissue. Medtech Insight met with CorNeat's CEO, Almog Aley-raz and CMO, Gilad Litvin at the OurCrowd Global Investor in Jerusalem, February 13, to hear more.